While complying with local directives, Cellecta is fully operational. Normal turnaround times have not been affected by COVID-19 more >
Catalog #: SHCTL-NT-PRSIT17
$300.00
Tet-inducible non-targeting shRNA in a standard lentiviral construct. The U6 promoter driving shRNA expression is responsive to the tetracycline analog doxocycline. Used as a negative control for RNAi studies.